Potential use of lipoxygenase inhibitors for cancer chemoprevention

Author： Steele V.E.   Holmes C.A.   Hawk E.T.   Kopelovich L.   Lubet R.A.   Crowell J.A.   Sigman C.C.   Kelloff G.J.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.9, 2000-09, pp. : 2121-2138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Five-Lipoxygenase Pathway of Arachidonic Acid Metabolism in Carcinogenesis and Cancer Chemoprevention

By  

Current Cancer Drug Targets, Vol. 6, Iss. 7, 2006-11 ,pp. : 613-622

Bentham Science Publishers

Access to resources Recommend Favorite

Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy

By Koki A.T.   Leahy K.M.   Masferrer J.L.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1623-1638

Informa Healthcare

Access to resources Recommend Favorite

Lipoxygenase Inhibitors for Cancer Prevention: Promises and Risks

By  

Current Pharmaceutical Design, Vol. 16, Iss. 6, 2010-02 ,pp. : 725-733

Bentham Science Publishers

Access to resources Recommend Favorite

The Potential of Statins for Individualized Colorectal Cancer Chemoprevention

By  

Current Drug Targets, Vol. 12, Iss. 13, 2011-12 ,pp. : 1903-1908

Bentham Science Publishers

Access to resources Recommend Favorite

Chemoprevention of Colorectal Cancer: Ready for Routine Use?

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 5, 2005-06 ,pp. : 517-525

Bentham Science Publishers

Access to resources Recommend Favorite